Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ruxolitinib”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03386214
What this trial is testing

Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis

Who this might be right for
Myelofibroses
Washington University School of Medicine 8
Testing effectiveness (Phase 2)Study completedNCT03194542
What this trial is testing

A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated Myelofibrosis Who Have Anemia With and Without Red Blood Cell-transfusion Dependence

Who this might be right for
Primary MyelofibrosisAnemia
Celgene 95
Testing effectiveness (Phase 2)Ended earlyNCT03123588
What this trial is testing

Phase 2 Study of Ruxolitinib Versus Anagrelide in Subjects With Essential Thrombocythemia Who Are Resistant to or Intolerant of Hydroxyurea (RESET-272)

Who this might be right for
MPN (Myeloproliferative Neoplasms)
Incyte Corporation 12
Very early researchWithdrawnNCT02593929
What this trial is testing

Pharmacodynamic Effects and Predictive Biomarkers With Ruxolitinib in Operable Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell Carcinoma
University of Pittsburgh
Post-approval studies (Phase 4)Looking for participantsNCT06824103
What this trial is testing

Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease

Who this might be right for
Graft vs. Host DiseaseChronic Graft vs. Host DiseaseCorticosteroid-refractory Chronic Graft vs. Host Disease
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06664970
What this trial is testing

Study on the Treatment of MDS/MPN Overlap Syndrome With AZA or Rux Combined With Selinexor

Who this might be right for
MDS
Peking Union Medical College Hospital 39
Not applicableWithdrawnNCT02469974
What this trial is testing

Ruxolitinib in Combination With Autotransplant

Who this might be right for
MyelofibrosisMF
Marina Kremyanskaya
Testing effectiveness (Phase 2)Study completedNCT02966353
What this trial is testing

Efficacy and Safety of Ruxolitinib in the Treatment of Anemic Myelofibrosis Patients.

Who this might be right for
Primary MyelofibrosisPost-Polycythemia Vera-MyelofibrosisPost-Essential Thrombocythemia Myelofibrosis
Novartis Pharmaceuticals 51
Testing effectiveness (Phase 2)Study completedNCT04851535
What this trial is testing

Study of Jaktinib In Patients With Myelofibrosis Who Were Relapsed or Refractory of Ruxolitinib Treatment.

Who this might be right for
Myelofibrosis
Suzhou Zelgen Biopharmaceuticals Co.,Ltd 34
Early research (Phase 1)Study completedNCT02253277
What this trial is testing

Safety and Tolerability of Combined Treatment With Nilotinib and Ruxolitinib in CML and Ph+ ALL Patients

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 5
Testing effectiveness (Phase 2)Looking for participantsNCT06477549
What this trial is testing

BeFluBu vs FluBuRux Conditioning in Haploidentical HCT

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaBiphenotypic Acute Leukemia+3 more
St. Petersburg State Pavlov Medical University 220
Not applicableLooking for participantsNCT07594587
What this trial is testing

Ruxolitinib in Patients With Graft-Versus Host Disease

Who this might be right for
Graft-Versus-Host Disease
Novartis Pharmaceuticals 395
Testing effectiveness (Phase 2)UnknownNCT05095649
What this trial is testing

Donor Regulatory T-cells for cGVHD in Patients Who do Not Obtain Complete Remission With Ruxolitinib

Who this might be right for
Chronic Graft vs Host Disease
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 15
Large-scale testing (Phase 3)Looking for participantsNCT07623161
What this trial is testing

Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

Who this might be right for
MyelofibrosisAnemia
Takeda 324
Early research (Phase 1)Looking for participantsNCT07588139
What this trial is testing

Evaluate Dermal Open-Flow Microperfusion and Plasma Pharmacokinetic Study of Multiple Doses of Oral Povorcitinib or Topical Ruxolitinib Cream in Healthy Adult Participants

Who this might be right for
Healthy Participants
Incyte Corporation 24
Early research (Phase 1)Active Not RecruitingNCT02494882
What this trial is testing

Adding Ruxolitinib to a Combination of Dasatinib Plus Dexamethasone in Remission Induction Therapy in Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patients Aged 40 Years or Older

Who this might be right for
Acute Lymphoblastic Leukemia
Memorial Sloan Kettering Cancer Center 12
Large-scale testing (Phase 3)UnknownNCT05137496
What this trial is testing

Ruxolitinib and Methylprednisolone as a First-line Treatment for Macrophage Activation Syndrome

Who this might be right for
Macrophage Activation Syndrome
Beijing Friendship Hospital 40
Testing effectiveness (Phase 2)Study completedNCT02953678
What this trial is testing

Ruxolitinib in Combination With Corticosteroids for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease (REACH-1)

Who this might be right for
Graft-versus-host Disease (GVHD)
Incyte Corporation 71
Not applicableLooking for participantsNCT06259669
What this trial is testing

Study to Compare Maternal, Fetal, and Infant Outcomes of Women With Mild to Moderate Atopic Dermatitis Exposed to Ruxolitinib Cream During Pregnancy With an Unexposed Control Population

Who this might be right for
Pregnancy RelatedAtopic Dermatitis
Incyte Corporation 958
Testing effectiveness (Phase 2)Study completedNCT02076191
What this trial is testing

Study of Combination Ruxolitinib and Decitabine Treatment for Accelerated Phase MPN or Post-MPN AML

Who this might be right for
Myeloproliferative Neoplasms
John Mascarenhas 49
Next Page